Please Wait...

Upcoming Webinar: Clinical Payments Case Studies: Improving Efficiency, Cash Management, and Compliance

Join us for our upcoming webinar on September 26th during which Bioclinica expert, Lorie McClain, Vice President of Product Management, Product Development & Technology, will present and discuss case studies providing insight into how improvements in clinical payments can make your clinical trials more efficient, while improving your cash management and compliance.

Site satisfaction remains an important consideration in all clinical trials. At the same time, trial sponsors and CROs benefit from more accurate and timely financial decisions and projections. Automating the clinical payments process and centralizing access to financial reporting and metrics benefit all stakeholders.

The presented case studies will provide examples of:

  • Clinical payment automation, to improve accuracy and operational efficiency and to gain greater control over cash management
  • Accurate and timely financial decisions and projections that are based on relevant financial and operational data
  • Identification of payment trends
  • Accurate forecasting based on trial actuals
  • Quick and accurate calculation of accruals to track current liabilities for payments
  • Increased transparency and advanced visibility of the payment process and forecasts for all stakeholders
  • Streamlined reporting
  • Compliance with the Sunshine Act
  • Increased site satisfaction and becoming the "partner of choice" for high-performing sites by replacing error-prone, manual methods with fast and accurate data-driven processes

To join us for this webinar and learn more, register here.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @endpts: #FDA revises draft guidance on #raredisease drug R&D https://t.co/KaNVw54MDE by @ZacharyBrennan via @RAPSorg
Bioclinica (12 hours ago)
RT @PrimeVigilance: News and Press Release - Source @EMA_News now available monthly meeting highlights from #Pharmacovigilance #RiskAssessm…
Bioclinica (12 hours ago)
RT @FDA_Drug_Info: New #FDA Draft Guidance for Industry on Rare Diseases – Common Issues in Drug Development: https://t.co/yxaGyMB7hY. http…
Bioclinica (12 hours ago)
Looking to exercise DDDM in clinical trials? Get tips on obtaining, distilling and presenting data in our new white… https://t.co/NkGrS9JnG8
Bioclinica (14 hours ago)
Is your clinical study supply chain management solution increasing the risk of stock out? Ehsan Ramezani gives pers… https://t.co/YCfP3wCvK6
Bioclinica (Yesterday)
Bioclinica's Kate Adamczuk is presenting at #HAI2019 today! Details on this and other scientific findings at HAI… https://t.co/wDQr6ldfcS
Bioclinica (Yesterday)

Latest Blogs:

Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner